Evaluation Of Balance And Ankle Proprioception In Calcaneal Spur Patients (CS)

December 14, 2024 updated by: Mai Afifi Saad Mohamed Farahat, Cairo University
this study will be conducted to investigate the difference in balance and ankle proprioception between calcaneus spur patients and age matched normal subjects

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

A calcaneal spur, also known as enthesophyte, is an abnormal bone outgrowth at the inferior part of the calcaneus, which is the most common site of bony spur occurrence. Although there is consensus that a calcaneal spur is a common cause of heel pain, approximately 20% of calcaneal spurs are asymptomatic and its pathology remains not fully understood.Ankle Joint Position Sense (JPS) refers to the ability to accurately perceive and reproduce the position of the ankle joint in space. Balance, on the other hand, encompasses the ankle joint's positional stability during both static and dynamic activities.Several investigations have demonstrated a significant association between ankle JPS and balance, indicating that individuals with better proprioceptive acuity in the ankle joint tend to exhibit superior postural stability, ). It was found that higher plantar fascia and heel fat pad stiffness and thickness are related to higher postural sway in anterior-posterior and medial-lateral directions based on the single-leg balance tests. These results suggest that the morphological and mechanical properties of plantar fascia and heel fat pad play an important role in balance performance.

Study Type

Observational

Enrollment (Estimated)

52

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

fifty two subjects will be assigned to two group; group with calcaneal spur and healthy group

Description

Inclusion Criteria:

  • age will range from 40-60
  • both sex male and female
  • unilateral calcaneal spur
  • Patients with pain and inflammation at the bottom of heel, or the location where the spur is present.
  • All subjects have body mass index less than 29 kg/cm2
  • sharp pain like a knife in the heel when standing up in the morning
  • pain may also appear at the end of the day or after spending long periods of time on the feet
  • sharp pain with the first steps in the morning or after a long period of rest and dissipating when weight bearing is initiated.
  • All diagnosed patients, were evaluated and confirmed radiologically by specialist doctor, by performing a standard X-ray foot profile image

Exclusion Criteria:

  • Surgery within the last 6 months
  • Sensory or motor paralysis -Received steroid injections within the last 3 months-
  • discrepancy in length of the lower extremities greater than or equal to 1 cm.
  • systemic disease in the last six months that may predispose to heel pain(e.g., rheumatoid arthritis and lupus). (Dudoniene V et al.,2023).
  • Calcaneal spurs are associated with various medical conditions, including obesity, rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, Reiter's disease, and spondylarthritis.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
calcaneal spur group
twenty six patients with calcaneal spur will participate in this group
healthy group
twenty six healthy subjects will participate in this group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
dynamic balance
Time Frame: up to one day
the Biodex Balance System (BBS) ,Version 3.1, has been used to evaluate postural balance
up to one day
static balance
Time Frame: up to one day
The single-leg stance balance test will be used to assess static balance.
up to one day
ankle propriception
Time Frame: up to one day
digital inclinometer will be used to assessed ankle proprioception
up to one day
foot disability
Time Frame: up to one day
A Foot Function Index (FFI) will be used to assess foot disability. The pain subcategory consists of 9 items and measures foot pain in different situations, such as walking barefoot versus walking with shoes. The disability subcategory consists of 9 items and measures difficulty performing various functional activities because of foot problems, such as difficulty climbing stairs. The activity limitation subcategory consists of 5 items and measures limitations in activities because of foot problems, such as staying in bed all day. Recorded on a visual analogue scale (VAS), scores range from 0 to 100 mm, with higher scores indicating worse pain. Both total and subcategory scores are calculated
up to one day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
integrity of the plantar fascia ligament
Time Frame: up to one day
The Windlass Test is a physical examination technique will be used to assess the integrity of the plantar fascia ligament in the foot. we evaluated the Windlass test, and found it had a high specificity, and a low level of sensitivity. It can be used as part of the clinician's armamentarium in evaluating patients with plantar fasciitis, and should be performed in a weightbearing position to maximize the sensitivity
up to one day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 25, 2024

Primary Completion (Estimated)

January 30, 2025

Study Completion (Estimated)

January 30, 2025

Study Registration Dates

First Submitted

December 14, 2024

First Submitted That Met QC Criteria

December 14, 2024

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

December 14, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • P.T.REC/012/005501

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe